Anton P, Tanke H J, Allehoff E P, Kuczyk M A, Stief C G, Jonas U
Department of Urology, Medizinische Hochschule Hannover, Germany.
World J Urol. 1995;13(3):149-52. doi: 10.1007/BF00184869.
To spare organ function, partial resection of early diagnosed renal-cell carcinoma (RCC) is applied for well-localized and small-volume RCC with increasing frequency, although recurrence of the tumor in the same kidney is occasionally observed. The aim of the present study was to establish objective prognostic parameters that would allow the selection of tumors suitable for an organsaving procedure. Of the 160 patients undergoing a radical nephrectomy, 67 were included in this study. In 7/45 patients with lymph-node dissection (15.6%), clinical staging revealed a false-negative lymph-node status. By means of conventional histopathology, multifocality could be demonstrated in 2/67 patients (3%); in 1/67 patients (1.5%), the ipsilateral adrenal gland was unexpectantly tumor-involved. Both tumor tissue and normal peritumoral tissue were examined for the presence of premalignant and tumor cells on the basis of DNA ploidy and of the expression of the tumor-associated G250 antigen, which is specifically expressed at the surface of renal cancer cells. In 40/67 (59.1%) peritumoral tissue specimens, cells with an abnormal DNA content could be observed using automated image analysis. In 12/67 cases (18%), cells obtained from peritumoral tissue also showed an aneuploid DNA histogram; 4/67 (6%) had a tumor-correlated DNA ploidy. Additionally, 38/67 (56.9%) of these tissues, histopathologically classified as normal, contained cells expressing the G250 antigen. These observations were independent of the stage or histological grade of the tumor. These data indicate that classic pathological parameters for tumor staging are insufficient for the detection of multifocality, occurring in more than 15% of cases.(ABSTRACT TRUNCATED AT 250 WORDS)
为保留器官功能,早期诊断的肾细胞癌(RCC)的部分切除术越来越频繁地应用于定位良好且体积较小的RCC,尽管偶尔会观察到同一肾脏内肿瘤复发。本研究的目的是建立客观的预后参数,以便选择适合保留器官手术的肿瘤。在160例行根治性肾切除术的患者中,67例纳入本研究。在45例行淋巴结清扫术的患者中,7例(15.6%)临床分期显示淋巴结状态为假阴性。通过传统组织病理学检查,67例患者中有2例(3%)显示多灶性;67例患者中有1例(1.5%)同侧肾上腺意外受累。基于DNA倍体和肿瘤相关G250抗原的表达,对肿瘤组织和肿瘤周围正常组织进行检查,以确定是否存在癌前细胞和肿瘤细胞,G250抗原在肾癌细胞表面特异性表达。在67例患者中的40例(59.1%)肿瘤周围组织标本中,使用自动图像分析可观察到DNA含量异常的细胞。在67例病例中的12例(18%)中,从肿瘤周围组织获得的细胞也显示非整倍体DNA直方图;4例(6%)具有与肿瘤相关的DNA倍体。此外,这些组织中67例的38例(56.9%),组织病理学分类为正常,但含有表达G250抗原的细胞。这些观察结果与肿瘤的分期或组织学分级无关。这些数据表明,用于肿瘤分期的经典病理参数不足以检测出超过15%病例中出现的多灶性。(摘要截断于250字)